Henry Schein, Inc. (HSIC)

US — Healthcare Sector
Peers: OMI  ABC  CAH  ZYXI  PDCO  EDAP  MCK 

Automate Your Wheel Strategy on HSIC

With Tiblio's Option Bot, you can configure your own wheel strategy including HSIC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol HSIC
  • Rev/Share 102.3542
  • Book/Share 38.1253
  • PB 2.6389
  • Debt/Equity 0.974
  • CurrentRatio 1.384
  • ROIC 0.0581

 

  • MktCap 8589780400.0
  • FreeCF/Share 4.185
  • PFCF 16.5826
  • PE 21.4616
  • Debt/Assets 0.3076
  • DivYield 0
  • ROE 0.1187

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 2
  • DCF Score 4
  • P/B Score 2
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation HSIC Wells Fargo -- Equal Weight -- $80 Feb. 14, 2025
Upgrade HSIC BofA Securities Underperform Buy $69 $84 Jan. 6, 2025
Initiation HSIC Mizuho -- Neutral -- $75 Dec. 4, 2024

News

Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue?
HSIC
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

Read More
image for news Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue?
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
HSIC
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
HSIC
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business.

Read More
image for news Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Henry Schein to Participate in Upcoming Investor Conferences in May
HSIC
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in May: Bank of America Healthcare Conference at the Encore Hotel in Las Vegas on May 14, 2025, at 10:00 a.m. Pacific time (1:00 p.m. Eastern time). Stifel Jaws & Paws Conference at Lotte Hotel, New York City, on May 29, 2025, at 12:40 p.m. Eastern time.

Read More
image for news Henry Schein to Participate in Upcoming Investor Conferences in May
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics
HSIC
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Positive

Although the revenue and EPS for Henry Schein (HSIC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Read More
image for news Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics
Henry Schein Q1 Earnings Top Estimates, Revenues Miss, Stock Falls
HSIC
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Negative

HSIC ends the first quarter of 2025 on a mixed note.

Read More
image for news Henry Schein Q1 Earnings Top Estimates, Revenues Miss, Stock Falls
Henry Schein: An Industry Leader That Offers Some Upside From Here
HSIC
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Positive

Henry Schein is the world's largest provider of healthcare products and services for office-based dental and medical practitioners, showing consistent growth through acquisitions. Despite a 3% dip in shares, management's 2025 guidance indicates continued growth, justifying a bullish stance on the stock. The firm reported a 5.8% revenue increase in Q4 2024, driven by organic growth and acquisitions, with significant improvements in net income and operating cash flow.

Read More
image for news Henry Schein: An Industry Leader That Offers Some Upside From Here
HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
HSIC
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Henry Schein's fourth-quarter results reflect stable dental and medical end-markets.

Read More
image for news HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
HSIC
Published: February 25, 2025 by: Business Wire
Sentiment: Neutral

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and full year ended December 28, 2024. The financial results and guidance being provided today are consistent with the preliminary financial results and guidance provided on January 29th. “Our fourth quarter financial results reflect relatively stable dental and medical.

Read More
image for news Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
HSIC Gears Up for Q4 Earnings: Here's What You Need to Know
HSIC
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive

Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.

Read More
image for news HSIC Gears Up for Q4 Earnings: Here's What You Need to Know

About Henry Schein, Inc. (HSIC)

  • IPO Date 1995-11-03
  • Website https://www.henryschein.com
  • Industry Medical - Distribution
  • CEO Mr. Stanley M. Bergman CPA
  • Employees 25000

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.